Farinati, Fabio

Publishing since 1981 (Dinosaur)

Has published 168 publications in 30 years

Number of publications published per year by Farinati, Fabio. (Source : PubMed)

Distribution of publications types for Farinati, Fabio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kotsafti A, Farinati F, Cardin R, Burra P, Bortolami M. Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases.  BMC Gastroenterol  2010;10;1  
•  Giannini EG, Savarino V, Risso D, Nolfo MA, Poggio PD, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F. Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.  Liver Int.  2010  
•  Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, Frigerio M, Maraldi F, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M, Trevisani F. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience.  Gut  2010;59;3  
•  Giannini EG, Bodini G, Corbo M, Savarino V, Risso D, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.  Aliment. Pharmacol. Ther.  2010;31;4  
•  Giacomin A, Sergio A, Vanin V, Tartaro P, Paccagnella D, Mazzucco M, Farinati F. Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre-sorafenib era.  Hepatol. Res.  2010  
•  Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.  Hepatology  2010;51;1  
•  Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?  Eur J Gastroenterol Hepatol  2009;21;10  
•  Cavazza A, Caballería L, Floreani A, Farinati F, Bruguera M, Caroli D, Parés A. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.  Hepatology  2009;50;4  
•  Vitale A, Saracino E, Boccagni P, Brolese A, D'Amico F, Gringeri E, Neri D, Srsen N, Valmasoni M, Zanus G, Carraro A, Violi P, Pauletto A, Bassi D, Polacco M, Burra P, Farinati F, Feltracco P, Romano A, D'Amico DF, Cillo U. Validation of the BCLC prognostic system in surgical hepatocellular cancer patients.  Transplant. Proc.  2009;41;4  
•  Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M. Hepatocellular carcinoma in patients with cryptogenic cirrhosis.  Clin. Gastroenterol. Hepatol.  2009;7;5  

[ See timeline ] [ See all publications ]